Economic impact of the introduction of the ProC® global assay in the screening strategy of protein C pathway abnormalities in unselected patients with a history of venous thromboembolism

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 720-721

  Toulon, P ^a   Adda, R ^a   Perez, P ^a  

^a Laboratoire d'Hématologie ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; ASSAY; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD CLOTTING; COHORT ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC TEST; ECONOMIC ASPECT; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0034909710     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616116     Document Type: Letter

References (12)

1. The PCAT - A simple screening assay for assessing the functionality of the protein C anticoagulant pathway
2. Screening for abnormalities of the protein C anticoagulant pathway using the ProC global assay. Results of a European multicenter trial
3. ProC® global assay is an independent predictor for venous thromboembolism
4. ProC® global screening test and the risk of thrombosis
5. ProC® global: The first functional screening assay for the complete protein C pathway
6. Inherited thrombophilia. Part 1
7. The anticoagulant potential of the protein C system in hereditary and acquired thrombophilia: Pathomechanisms and new tools for assessing its clinical relevance
8. Evaluation of a new screening assay ProC® global for identification of defects in the protein C/protein S anticoagulant pathway
9. Laboratory screening of thrombophilia. Evaluation of the diagnostic efficacy of a global test to detect congenital deficiencies of the protein C anticoagulant pathway
10. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype
11. ProC global, a new assay to evaluate the functionality of the protein C anticoagulant pathway. Preliminary results in 223 consecutive patients with a history of venous thromboembolism
12. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals